Header Logo

Connection

MITCHELL FREDERICK to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications MITCHELL FREDERICK has written about Erlotinib Hydrochloride.
MITCHELL FREDERICK
Connection Strength
0.027
Erlotinib Hydrochloride
  1. HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells. Head Neck. 2014 Nov; 36(11):1547-54.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.